Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Health
Vandana Singh

Cardiovascular Systems, OrbusNeich Scores FDA Approval For Scoreflex Scoring Balloon

Cardiovascular Systems Inc (NASDAQ:CSII), along with OrbusNeich Medical Company Ltd, have received FDA PMA approval for OrbusNeich's Scoreflex NC Scoring Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter (Scoreflex NC).

  • Scoreflex NC is a focused force PTCA scoring balloon with a dual-wire system that creates a focal stress pattern to facilitate safe and controlled plaque modification at lower resolution pressure. 
  • Scoreflex NC is indicated for the dilatation of a de novo stenotic portion of a coronary artery and in-stent restenosis in patients evidencing coronary ischemia to improve myocardial perfusion.
  • Related: Cardiovascular Systems To Develop IVL Technology For Coronary, Peripheral Artery Diseases.
  • A pivotal study was performed with 200 patients being treated. 
  • The study results support the acute safety and device success of the Scoreflex NC - Scoring PTCA Catheter and its intended use as a dilatation catheter in the stenotic portion of coronary artery stenosis (≥70% diameter stenosis).
  • Price Action: CSII shares closed at $17.73 on Wednesday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.